GLP-1 Anticorps

Your search for reliable GLP-1 antibodies ends here. GLP-1, known by aliases such as GCG, Gcg, is an integral part of our antibody range. Whether you're working with Human, Rat, Mouse, Cow, Dog, or other species, our range of GLP-1 antibodies offer precise detection across diverse samples. These specialized antibodies are tailored for various scientific applications like IF (cc), IF (p), ELISA, WB, IHC, providing you with options like polyclonal, recombinant, and monoclonal antibodies, sourced from different host species such as Rabbit, Mouse, Goat. The efficacy of our antibodies is well-established, demonstrated through multiple methods.

Detailed information, including references, images, and validations by other customers, can be found on each product page. Should you require assistance in finding a specific product, our customer service team is ready to assist. Utilize our GLP-1 antibodies in your research endeavors for dependable GLP-1 detection.

About GLP-1

Glucagon-like peptide-1 (GLP-1) is a hormone that plays a crucial role in glucose homeostasis and metabolism. GLP-1 antibodies are valuable research tools for further exploring the role of GLP-1. GLP-1 is produced in the gut and released in response to food intake. The main actions of GLP-1 are to stimulate insulin secretion from the pancreas and inhibit glucagon secretion, which helps to regulate blood sugar levels. GLP-1 also slows down gastric emptying, reduces appetite, and promotes satiety, leading to decreased food intake. Additionally, GLP-1 has been shown to have protective effects on pancreatic beta cells, promoting their survival and function. GLP-1 has been used as a therapeutic target for the treatment of type 2 diabetes, as GLP-1 receptor agonists (GLP-1RAs) can enhance insulin secretion, improve glycemic control, and promote weight loss. Overall, the role of GLP-1 is to regulate glucose metabolism, promote insulin secretion, inhibit glucagon secretion, and regulate appetite and food intake. Recently GLP-1 has attract broader attention as a GLP-1 receptor agonist drug (Semaglutide) has been approved by the FDA and EMA. Semaglutide targets areas of the brain that regulate appetite and food intake. This leads to a reduction in appetite, helping individuals eat fewer calories and lose weight.